Inventor profile of:

David A. WEBER

City:

Danville, California

Country:

United States

Published Applications:

51

Last publication date:

2025-10-16

Top Assignees for applications by David A. WEBER

The entities that hold a legal rights for patent applications filed by inventor WEBER David A.:

Recent patent applications by WEBER David A.

David A. WEBER from Danville, US has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2025-10-16
US20250319031A1
Human necessities

METHODS OF TREATMENT OF OCULAR CONDITIONS WITH A SUSTAINED DRUG DELIVERY IMPLANT

#2 | 2024-07-18
US20240238312A1
Human necessities

OCULAR IMPLANT MADE BY A DOUBLE EXTRUSION PROCESS

#3 | 2023-06-08
US20230172948A1
Human necessities

OCULAR IMPLANT MADE BY A DOUBLE EXTRUSION PROCES

#4 | 2021-04-22
US20210113592A1
Human necessities

OCULAR IMPLANT MADE BY A DOUBLE EXTRUSION PROCES

#5 | 2019-01-17
US20190015425A1
Human necessities

Ocular implant made by a double extrusion process

#6 | 2018-11-01
US20180311152A1
Human necessities

LIQUID FORMULATIONS FOR TREATMENT OF DISEASES OR CONDITIONS

#7 | 2017-09-21
US20170266109A1
Human necessities

RAPAMYCIN FORMULATIONS AND METHODS OF THEIR USE

#8 | 2017-02-23
US20170049786A1
Human necessities

MTOR PATHWAY INHIBITORS FOR TREATING OCULAR DISORDERS

#9 | 2017-01-26
US20170020809A1
Human necessities

LIQUID FORMULATIONS FOR TREATMENT OF DISEASES OR CONDITIONS

#10 | 2016-10-20
US20160303093A1
Human necessities

RAPAMYCIN FORMULATIONS AND METHODS OF THEIR USE

#11 | 2016-03-17
US20160074418A1
Human necessities

Ocular implant made by a double extrusion process

#12 | 2015-09-24
US20150265581A1
Human necessities

Formulations and methods for vascular permeability-related diseases or conditions

#13 | 2015-06-04
US20150150794A1
Human necessities

Liquid formulations for treatment of diseases or conditions

#14 | 2015-05-21
US20150140062A1
Human necessities

METHODS OF TREATMENT OF OCULAR CONDITIONS WITH A SUSTAINED DRUG DELIVERY IMPLANT

#15 | 2015-05-14
US20150133559A1
Human necessities

Methods for treating retinopathy with extended therapeutic effect

#16 | 2014-11-06
US20140328835A1
Human necessities

Methods for treating retinopathy with extended therapeutic effect

#17 | 2014-07-10
US20140194461A1
Human necessities

Rapamycin formulations and methods of their use

#18 | 2013-11-14
US20130302324A1
Human necessities

Methods for treating retinopathy with extended therapeutic effect

#19 | 2013-11-07
US20130295157A1
Human necessities

Ocular implant made by a double extrusion process

#20 | 2013-09-05
US20130231318A1
Human necessities

Ocular implant made by a double extrusion process

#21 | 2013-08-01
US20130197024A1
Human necessities

Liquid formulations for treatment of diseases or conditions

#22 | 2012-12-27
US20120329850A1
Human necessities

Methods for treating retinopathy with extended therapeutic effect

#23 | 2012-12-27
US20120329759A1
Human necessities

Formulations and methods for vascular permeability-related diseases or conditions

#24 | 2011-12-22
US20110309546A1
Human necessities

Ocular implant made by a double extrusion process

#25 | 2011-12-15
US20110305743A1
Human necessities

Ocular implant made by a double extrusion process

#26 | 2010-09-09
US20100227879A1
Human necessities

Liquid formulations for treatment of diseases or conditions

#27 | 2009-03-19
US20090074786A1
Human necessities

Formulations for treating ocular diseases and conditions

#28 | 2008-11-20
US20080286336A1
Human necessities

Ocular implant made by a double extrusion process

#29 | 2008-11-20
US20080286334A1
Human necessities

Ocular implant made by a double extrusion process

#30 | 2008-10-02
US20080241222A1
Human necessities

EXTENDED THERAPEUTIC EFFECT OCULAR IMPLANT TREATMENTS

#31 | 2008-10-02
US20080241221A1
Human necessities

EXTENDED THERAPEUTIC EFFECT OCULAR IMPLANT TREATMENTS

#32 | 2008-10-02
US20080241220A1
Human necessities

EXTENDED THERAPEUTIC EFFECT OCULAR IMPLANT TREATMENTS

#33 | 2008-10-02
US20080241219A1
Human necessities

EXTENDED THERAPEUTIC EFFECT OCULAR IMPLANT TREATMENTS

#34 | 2008-09-25
US20080233173A1
Human necessities

EXTENDED THERAPEUTIC EFFECT OCULAR IMPLANT TREATMENTS

#35 | 2008-09-25
US20080233172A1
Human necessities

EXTENDED THERAPEUTIC EFFECT OCULAR IMPLANT TREATMENTS

#36 | 2008-09-25
US20080233171A1
Human necessities

EXTENDED THERAPEUTIC EFFECT OCULAR IMPLANT TREATMENTS

#37 | 2008-07-17
US20080172014A1
Human necessities

EXTENDED THERAPEUTIC EFFECT OCULAR IMPLANT TREATMENTS

#38 | 2008-05-08
US20080107712A1
Human necessities

Ocular implant made by a double extrusion process

#39 | 2007-11-15
US20070265294A1
Human necessities

Formulations and methods for vascular permeability-related diseases or conditions

#40 | 2006-11-23
US20060264453A1
Human necessities

Rapamycin formulations and methods of their use

#41 | 2006-11-16
US20060258698A1
Human necessities

Liquid formulations for treatment of diseases or conditions

#42 | 2006-11-16
US20060257450A1
Human necessities

Drug delivery systems for treatment of diseases or conditions

#43 | 2006-10-26
US20060241650A1
Human necessities

Methods and apparatus for delivery of ocular implants

#44 | 2006-10-19
US20060233859A1
Human necessities

Methods for treating retinopathy with extended therapeutic effect

#45 | 2006-09-14
US20060204548A1
Human necessities

Microimplants for ocular administration

#46 | 2006-08-17
US20060182771A1
Human necessities

Formulations for ocular treatment

#47 | 2005-11-03
US20050244469A1
Human necessities

Extended therapeutic effect ocular implant treatments

#48 | 2005-09-15
US20050203542A1
Human necessities

Apparatus for delivery of ocular implants with reduced incidence of ocular adverse events

#49 | 2005-07-14
US20050154399A1
Human necessities

Apparatus for delivery of ocular implants

#50 | 2005-05-12
US20050101967A1
Human necessities

Methods and apparatus for delivery of ocular implants

#51 | 2005-03-03
US20050048099A1
Human necessities

Ocular implant made by a double extrusion process

InventorID:

367055 ⎘